Literature DB >> 19735342

The turning point: from self-regulative illness behaviour to care-seeking in patients with an acute myocardial infarction.

Carolin Nymark1, Anne-Cathrine Mattiasson, Peter Henriksson, Anna Kiessling.   

Abstract

AIMS AND
OBJECTIVES: To describe the care-seeking process from interpretation of an initial symptom to the decision to seek medical care in patients with an acute myocardial infarction.
BACKGROUND: Patients afflicted by symptoms of an acute myocardial infarction delay in seeking care far exceeding the desired time limits. This results in avoidable loss of life. There is thus a need to understand these patients' initial discomfort, appraisal and behaviour to design interventions that could reduce delay in care-seeking.
DESIGN: Focus group discussions with patients who had had a recent acute myocardial infarction.
METHODS: The analysis of the transcribed text was inspired by the self-regulatory model of illness behaviour.
RESULTS: Patients with acute myocardial infarction describe problems to identify the exact time of onset of often vague symptoms. Their experiences of symptoms did not match their expectations. These patients exhibit self-regulatory illness behaviour that seems to cause a considerable delay in care-seeking.
CONCLUSIONS: We found indications of a pertinent shift in appraisal and coping-strategy when a patient changes from self-regulative illness behaviour to seeking care - the turning point. This shift seems to be affected by several partly contradictory influences and it takes a considerable time for a person to reach this stage. All aspects of the patients' self-regulative illness behaviour have to be considered if we want patients to seek medical care more rapidly. RELEVANCE TO CLINICAL PRACTICE: Our findings are important to consider in future design of public health and rehabilitation strategies to save patient lives. To identify the turning point is a profitable way to deepen the understanding of patient behaviour during the initial phase of an acute myocardial infarction.

Entities:  

Mesh:

Year:  2009        PMID: 19735342     DOI: 10.1111/j.1365-2702.2009.02911.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  6 in total

1.  Perceptions of delay when afflicted by an acute myocardial infarction during the first wave of the COVID-19 pandemic.

Authors:  Johanna Granström; Pontus Lantz; Matthias Lidin; Maria Wahlström; Carolin Nymark
Journal:  Eur J Cardiovasc Nurs       Date:  2022-06-08       Impact factor: 3.593

2.  The Process of Care-seeking for Myocardial Infarction Among Patients With Diabetes.

Authors:  Karin Hellström Ängerud; Christine Brulin; Mats Eliasson; Ulf Näslund; Åsa Hörnsten
Journal:  J Cardiovasc Nurs       Date:  2015 Sep-Oct       Impact factor: 2.083

3.  Stoic beliefs and health: development and preliminary validation of the Pathak-Wieten Stoicism Ideology Scale.

Authors:  Elizabeth B Pathak; Sarah E Wieten; Christopher W Wheldon
Journal:  BMJ Open       Date:  2017-11-14       Impact factor: 2.692

4.  'Just like a normal pain', what do people with diabetes mellitus experience when having a myocardial infarction: a qualitative study recruited from UK hospitals.

Authors:  Nikita Berman; Melvyn Mark Jones; Daan A De Coster
Journal:  BMJ Open       Date:  2017-09-15       Impact factor: 2.692

5.  The MEDEA FAR-EAST Study: Conceptual framework, methods and first findings of a multicenter cross-sectional observational study.

Authors:  Sophia Hoschar; Jiangqi Pan; Zhen Wang; Xiaoyan Fang; Xian'e Tang; Weiqi Shi; Rongxiang Tu; Peng Xi; Wenliang Che; Hongbao Wang; Yawei Li; Kurt Fritzsche; Xuebo Liu; Karl-Heinz Ladwig; Wenlin Ma
Journal:  BMC Emerg Med       Date:  2019-05-02

6.  Longer pre-hospital delay in first myocardial infarction among patients with diabetes: an analysis of 4266 patients in the northern Sweden MONICA Study.

Authors:  Karin Hellström Ängerud; Christine Brulin; Ulf Näslund; Mats Eliasson
Journal:  BMC Cardiovasc Disord       Date:  2013-01-29       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.